Infant Bacterial Therapeutics AB (publ)

BST:9IB Stock Report

Market Cap: €44.7m

Infant Bacterial Therapeutics AB (publ) Company Information

Infant Bacterial Therapeutics AB (publ)'s employee growth, exchange listings and data sources

Key Information

  • Name: Infant Bacterial Therapeutics AB (publ)
  • Ticker: 9IB
  • Exchange: BST
  • Founded: 2011
  • Industry: Pharmaceuticals
  • Sector: Pharmaceuticals & Biotech
  • Market Cap: SEK 514.608m
  • Listing Market Cap: SEK 44.749m
  • Shares Outstanding: 13.47m
  • Website: https://www.ibtherapeutics.com

Number of Employees

Location

  • Infant Bacterial Therapeutics AB (publ)
  • Bryggargatan 10
  • Stockholm
  • Stockholm County
  • 111 21
  • Sweden

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
IBT BOM (OMX Nordic Exchange Stockholm)YesClass B SharesSESEKMar 2016
IFTB.FOTCPK (Pink Sheets LLC)YesClass B SharesUSUSDMar 2016
9IBBST (Boerse-Stuttgart)YesClass B SharesDEEURMar 2016

Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2024/11/24 09:57
End of Day Share Price 2024/11/22 00:00
Earnings2024/09/30
Annual Earnings2023/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.